We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Eli Lilly Gets Strongly Worded Untitled Letter From FDA About Trulicity Instagram Ad
Eli Lilly Gets Strongly Worded Untitled Letter From FDA About Trulicity Instagram Ad
The FDA has slapped Eli Lilly with an Untitled Letter over what it calls a “misleading” and “particularly concerning” ad the company posted on Instagram for its type 2 diabetes drug Trulicity.